Joshua W. Wang

1.0k total citations
17 papers, 757 citations indexed

About

Joshua W. Wang is a scholar working on Epidemiology, Immunology and Surgery. According to data from OpenAlex, Joshua W. Wang has authored 17 papers receiving a total of 757 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Epidemiology, 10 papers in Immunology and 4 papers in Surgery. Recurrent topics in Joshua W. Wang's work include Cervical Cancer and HPV Research (15 papers), Immunotherapy and Immune Responses (9 papers) and Hepatitis B Virus Studies (5 papers). Joshua W. Wang is often cited by papers focused on Cervical Cancer and HPV Research (15 papers), Immunotherapy and Immune Responses (9 papers) and Hepatitis B Virus Studies (5 papers). Joshua W. Wang collaborates with scholars based in United States, Austria and United Kingdom. Joshua W. Wang's co-authors include Richard B.S. Roden, Shiwen Peng, Chien‐Fu Hung, Rosie Jiang, Kihyuck Kwak, Subhashini Jagu, Chenguang Wang, Balasubramanyam Karanam, Reinhard Kirnbauer and Ming Zhao and has published in prestigious journals such as PLoS ONE, Cancer Cell and Journal of Virology.

In The Last Decade

Joshua W. Wang

17 papers receiving 749 citations

Peers

Countries citing papers authored by Joshua W. Wang

Since Specialization

Citations

This map shows the geographic impact of Joshua W. Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joshua W. Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joshua W. Wang more than expected).

Fields of papers citing papers by Joshua W. Wang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joshua W. Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joshua W. Wang. The network helps show where Joshua W. Wang may publish in the future.

Co-authorship network of co-authors of Joshua W. Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Joshua W. Wang. A scholar is included among the top collaborators of Joshua W. Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joshua W. Wang. Joshua W. Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

#	Work	Indexed citations
1	Roles of Fc Domain and Exudation in L2 Antibody-Mediated Protection against Human Papillomavirus 2018 ·Journal of Virology ·Joshua W. Wang, (unknown), Tsui‐Chin Huang, Margaret Wong, Kihyuck Kwak, Keiko Ozato, Chien‐Fu Hung, Richard B.S. Roden	22
2	Spontaneous and Vaccine-Induced Clearance of Mus Musculus Papillomavirus 1 Infection 2017 ·Journal of Virology ·Rosie Jiang, Joshua W. Wang, Shiwen Peng, Tsui‐Chin Huang, Chenguang Wang, (unknown), Yung‐Nien Chang, Raphael P. Viscidi, Simon R. Best, Chien‐Fu Hung, Richard B.S. Roden	25
3	Optimization of heterologous DNA-prime, protein boost regimens and site of vaccination to enhance therapeutic immunity against human papillomavirus-associated disease 2016 ·Cell & Bioscience ·Shiwen Peng, Jin Qiu, Andrew Yang, Benjamin Yang, Jessica Jeang, Joshua W. Wang, Yung‐Nien Chang, Cory Brayton, Richard B.S. Roden, Chien‐Fu Hung, T.‐C. Wu	23
4	Sequential Cisplatin Therapy and Vaccination with HPV16 E6E7L2 Fusion Protein in Saponin Adjuvant GPI-0100 for the Treatment of a Model HPV16+ Cancer 2015 ·PLoS ONE ·Shiwen Peng, Joshua W. Wang, Balasubramanyam Karanam, Chenguang Wang, Warner K. Huh, Ronald D. Alvarez, Sara I. Pai, Chien‐Fu Hung, T.‐C. Wu, Richard B.S. Roden	20
5	Durable immunity to oncogenic human papillomaviruses elicited by adjuvanted recombinant Adeno-associated virus-like particle immunogen displaying L2 17–36 epitopes 2015 ·Vaccine ·Subhashini Jagu, (unknown), Joshua W. Wang, Hatem Zayed, Margit Weghofer, Sarah A. Brendle, Karla K. Balogh, (unknown), Richard B.S. Roden, Neil D. Christensen	21
6	Immunologic Control of Mus musculus Papillomavirus Type 1 2015 ·PLoS Pathogens ·Joshua W. Wang, Rosie Jiang, Shiwen Peng, (unknown), Chien‐Fu Hung, Richard B.S. Roden	42
7	Seroepidemiology of Human Papillomavirus 16 (HPV16) L2 and Generation of L2-Specific Human Chimeric Monoclonal Antibodies 2015 ·Clinical and Vaccine Immunology ·Joshua W. Wang, Subhashini Jagu, (unknown), Raphael P. Viscidi, Anne Macgregor-Das, Jessica M. Fogel, Kihyuck Kwak, Sai Daayana, Henry C Kitchener, Peter L. Stern, Patti E. Gravitt, Cornelia L. Trimble, Richard B.S. Roden	18
8	Production of Furin‐Cleaved Papillomavirus Pseudovirions and Their Use for In Vitro Neutralization Assays of L1‐ or L2‐Specific Antibodies 2015 ·Current Protocols in Microbiology ·Joshua W. Wang, Ken Matsui, Yuanji Pan, Kihyuck Kwak, Shiwen Peng, Troy J. Kemp, Lígia A. Pinto, Richard B.S. Roden	11
9	Measurement of Neutralizing Serum Antibodies of Patients Vaccinated with Human Papillomavirus L1 or L2-Based Immunogens Using Furin-Cleaved HPV Pseudovirions 2014 ·PLoS ONE ·Joshua W. Wang, Subhashini Jagu, Chenguang Wang, Henry C Kitchener, Sai Daayana, Peter L. Stern, (unknown), Patricia M. Day, Warner K. Huh, Richard B.S. Roden	22
10	Impact of Inhibitors and L2 Antibodies upon the Infectivity of Diverse Alpha and Beta Human Papillomavirus Types 2014 ·PLoS ONE ·Kihyuck Kwak, Rosie Jiang, Joshua W. Wang, Subhashini Jagu, Reinhard Kirnbauer, Richard B.S. Roden	38
11	Control of HPV-associated tumors by innovative therapeutic HPV DNA vaccine in the absence of CD4+ T cells 2014 ·Cell & Bioscience ·Shiwen Peng, Liwen Song, Jayne Knoff, Joshua W. Wang, Yung‐Nien Chang, Drew Hannaman, T.‐C. Wu, Ronald D. Alvarez, Richard B.S. Roden, Chien‐Fu Hung	27
12	Immunoprevention of Human Papillomavirus–Associated Malignancies 2014 ·Cancer Prevention Research ·Joshua W. Wang, (unknown), Warner K. Huh, Cornelia L. Trimble, Richard B.S. Roden	25
13	A bis-Benzylidine Piperidone Targeting Proteasome Ubiquitin Receptor RPN13/ADRM1 as a Therapy for Cancer 2013 ·Cancer Cell ·Ravi Anchoori, Balasubramanyam Karanam, Shiwen Peng, Joshua W. Wang, Rosie Jiang, Toshihiko Tanno, Robert Z. Orlowski, William Matsui, Ming Zhao, Michelle A. Rudek, Chien‐Fu Hung, Xiang Chen, Kylie J. Walters, Richard B.S. Roden	125
14	Preparation and properties of a papillomavirus infectious intermediate and its utility for neutralization studies 2013 ·Virology ·Joshua W. Wang, Subhashini Jagu, Kihyuck Kwak, Chenguang Wang, Shiwen Peng, Reinhard Kirnbauer, Richard B.S. Roden	35
15	Virus-like particles for the prevention of human papillomavirus-associated malignancies 2013 ·Expert Review of Vaccines ·Joshua W. Wang, Richard B.S. Roden	105
16	L2, the minor capsid protein of papillomavirus 2013 ·Virology ·Joshua W. Wang, Richard B.S. Roden	182
17	Multivalent Human Papillomavirus L1 DNA Vaccination Utilizing Electroporation 2013 ·PLoS ONE ·Kihyuck Kwak, Rosie Jiang, Subhashini Jagu, Joshua W. Wang, Chenguang Wang, Neil D. Christensen, Richard B.S. Roden	16

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact